Jason Wilson
Director/Board Member bij CytoSen Therapeutics, Inc.
Profiel
Jason D. Wilson, oprichter van Platial, Inc., is momenteel Executive Vice President-Operations bij Reata Pharmaceuticals, Inc. Hij zit ook in de raad van bestuur van CytoSen Therapeutics, Inc. Daarvoor was hij Vice President-Finance & Controller bij Inform Diagnostics, Inc., Vice President-Products bij Platial, Inc. en Senior Manager-Health Sciences Group bij Ernst & Young LLP. Hij behaalde een bachelor diploma aan de Henderson State University (Arkansas) en een MBA aan de University of Central Arkansas.
Actieve functies van Jason Wilson
Bedrijven | Functie | Begin |
---|---|---|
CytoSen Therapeutics, Inc.
CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Director/Board Member | - |
Eerdere bekende functies van Jason Wilson
Bedrijven | Functie | Einde |
---|---|---|
Inform Diagnostics, Inc.
Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Director of Finance/CFO | 01-01-2006 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
REATA PHARMACEUTICALS, INC. | Director of Finance/CFO | 28-08-2019 |
Opleiding van Jason Wilson
Henderson State University (Arkansas) | Undergraduate Degree |
University of Central Arkansas | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Inform Diagnostics, Inc.
Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Inform Diagnostics, Inc. provides pathology diagnostic services. It offers subspecialty anatomic pathology in the fields of breast health, dermatology, gastroenterology, hematology, and urology. The company was founded by David D. Halbert and Harold Roe in 1996 and is headquartered in Irving, TX. | Health Services |
CytoSen Therapeutics, Inc.
CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Commercial Services |